IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $924,000 | -19.5% | 26,249 | +5.0% | 0.02% | +40.0% |
| Q2 2015 | $1,148,000 | -6.7% | 24,997 | -4.8% | 0.02% | -6.2% |
| Q1 2015 | $1,230,000 | +30.2% | 26,249 | -12.0% | 0.02% | +100.0% |
| Q4 2014 | $945,000 | +10.1% | 29,840 | -17.6% | 0.01% | +14.3% |
| Q3 2014 | $858,000 | -21.9% | 36,194 | -1.2% | 0.01% | -84.8% |
| Q2 2014 | $1,099,000 | +1.5% | 36,633 | -10.6% | 0.05% | -4.2% |
| Q1 2014 | $1,083,000 | -16.6% | 40,985 | -20.6% | 0.05% | +45.5% |
| Q4 2013 | $1,298,000 | +15.8% | 51,624 | -5.7% | 0.03% | 0.0% |
| Q3 2013 | $1,121,000 | +2.1% | 54,746 | -0.6% | 0.03% | +106.2% |
| Q2 2013 | $1,098,000 | – | 55,053 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |